STOCK TITAN

Vestal Point discloses 5.1% Arcellx (ACLX) position in 13G

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Vestal Point Capital and Ryan Wilder have filed a Schedule 13G reporting beneficial ownership of 2,925,000 shares of Arcellx, Inc. common stock, representing 5.1% of the company’s outstanding shares.

The stake is held through the Vestal Point fund and a managed account, which have the right to receive dividends and sale proceeds. The ownership percentage is based on 57,822,871 Arcellx shares outstanding as of October 31, 2025. The filers certify the investment was made in the ordinary course of business and not for the purpose of influencing control of Arcellx.

Positive

  • None.

Negative

  • None.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Vestal Point Capital, LP
Signature:/s/ Ryan Wilder
Name/Title:By: Vestal Point Capital, LLC, General Partner, By: Ryan Wilder, Chief Investment Officer and Managing Partner
Date:02/17/2026
Ryan Wilder
Signature:/s/ Ryan Wilder
Name/Title:Ryan Wilder, Individually
Date:02/17/2026
Exhibit Information

Exhibit 99.1: Joint Filing Agreement

FAQ

What ownership stake in Arcellx (ACLX) did Vestal Point Capital report?

Vestal Point Capital and Ryan Wilder reported beneficial ownership of 2,925,000 Arcellx common shares, equal to 5.1% of the class. This percentage is calculated using 57,822,871 shares outstanding as of October 31, 2025, as disclosed in Arcellx’s Form 10-Q.

Who are the reporting persons in this Arcellx (ACLX) Schedule 13G filing?

The Schedule 13G is filed by Vestal Point Capital, LP, an investment manager, and Ryan Wilder, its Chief Investment Officer and Managing Partner. Both report beneficial ownership of the same 2,925,000 Arcellx common shares held by the Vestal Point fund and a managed account.

How was the 5.1% ownership in Arcellx (ACLX) calculated in the filing?

The 5.1% ownership figure is based on 57,822,871 Arcellx common shares outstanding as of October 31, 2025. That share count comes from Arcellx’s Form 10-Q for the quarter ended September 30, 2025, which the Schedule 13G cites when calculating the percentage.

Is Vestal Point Capital’s Arcellx (ACLX) investment described as passive or control-seeking?

The filing certifies the securities were acquired and are held in the ordinary course of business and not for the purpose or effect of changing or influencing control of Arcellx. It also states they are not held in connection with any transaction having that control-related purpose or effect.

Who has the right to dividends and sale proceeds from the Arcellx (ACLX) shares?

The Vestal Point Fund and Account have the right to receive, or direct the receipt of, dividends and proceeds from the sale of the Arcellx common shares reported. Vestal Point Capital, as investment manager, and Ryan Wilder report beneficial ownership related to those holdings.

What voting and dispositive powers are reported over Arcellx (ACLX) shares?

Both Vestal Point Capital and Ryan Wilder report shared voting power over 2,925,000 Arcellx shares and shared dispositive power over the same amount. They report no sole voting or sole dispositive power, indicating decisions are shared for those reported securities.